Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia

BACKGROUND: 30% of patients with polycystic ovary syndrome (PCOS) show mild, transient hyperprolactinemia. It is suggested that a reduction of the dopamine inhibitory effect might raise both prolactin and luteinizing hormone. Objective: To investigate the adjuvant cabergoline therapy effects on mens...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Iran J Reprod Med
Hlavní autoři: Ghaneei, Azam, Jowkar, Akram, Hasani Ghavam, Mohammad Reza, Ghaneei, Mohammad Ebrahim
Médium: Artigo
Jazyk:Inglês
Vydáno: Research and Clinical Center for Infertility 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4426146/
https://ncbi.nlm.nih.gov/pubmed/25999998
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky